H. Persson

H. Persson

Auto-generated profile, based on publicly available information

H. Persson

Department of Oral and Maxillofacial Surgery, Institute of Odontology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2025 in International Journal of Implant Dentistry
Verified
Journal Article
Open access
PDF file
HPH. Persson
H. Persson
CÖC. Östlund
C. Östlund
LRLars Rsasmusson
Lars Rsasmusson
JWJ. Walladbegi
J. Walladbegi
Background: Oral implantology has become a standard procedure for replacing missing teeth. However, patients with severe maxillary bone resorption often require complex surgical interventions, such as Le Fort I osteotomy with interpositional bone grafting, prior to implant placement. This study aimed to evaluate the long-term outcomes of oral implants placed following this surgical technique. Patients and methods: The present study was two-fold. First, a retrospective review was performed using medical records and conventional panoramic radiographs from 26 patients who had undergone Le Fort I osteotomy with interpositional bone grafting and received either Astra Tech or Brånemark oral implants. Patients were followed for up to 5 years. Marginal bone loss was measured from the implant shoulder to the bone level. Implant survival and success rates were assessed, with success defined as bone loss of ≤ 2 mm during the first year and < 0.2 mm annually thereafter. Second, to assess the long-term outcomes of the two oral implant systems, all traceable patients were invited to undergo a follow-up radiographic examination up to 29 years post-treatment. Results: The combined survival rates for Astra Tech and Brånemark oral implants were 97.0%, 94.6%, and 94.1% at 1, 2, and 3 years, respectively, with no additional implant loss observed by year 5. The overall success rate at 5 years was 56.1%, with Astra Tech implants showing a higher success rate (70.8%) compared to Brånemark implants (51.4%). Although there was no statistically significant difference in survival rates between the two systems, Astra Tech implants demonstrated significantly less marginal bone loss at both 1-year ( p < 0.01) and 3-year ( p = 0.021) follow-ups. For the long-term evaluation, 14 patients (54%) from the original cohort were traceable, of whom 4 patients (29%) participated in the follow-up. Among the 28 Brånemark implants assessed, none were lost, resulting in a 100% survival rate up to 29 years. The mean marginal bone loss of 2.6 ± 1.8 mm. Conclusion: Le Fort I osteotomy with interpositional bone grafting, followed by oral implant placement and prosthetic rehabilitation, appears to be a reliable long-term treatment option for patients with severe maxillary atrophy, demonstrating favorable long-term survival-, and success rates.